United Kingdom Ambulatory Cardiac Monitoring Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The United Kingdom Ambulatory Cardiac Monitoring Market is projected to grow at a CAGR of around 7.2%, driven by the rising prevalence of cardiovascular diseases, increasing adoption of remote patient monitoring, growing elderly population, and advancements in wearable cardiac monitoring technologies.
United Kingdom Ambulatory Cardiac Monitoring Market Forecasts to 2035
- The United Kingdom Ambulatory Cardiac Monitoring Market Size was estimated at USD 620.4 Million in 2025
- The Market Size is expected to grow at a CAGR of around 7.2% from 2025 to 2035
- The United Kingdom Ambulatory Cardiac Monitoring Market Size is expected to reach around USD 1,243.8 Million by 2035.
Notable Insights for the United Kingdom Ambulatory Cardiac Monitoring Market
- Segmentation based on product type indicates that Holter monitors, mobile cardiac telemetry (MCT) devices, and event monitors dominated the United Kingdom Ambulatory Cardiac Monitoring Market in 2025, accounting for around 59% share, driven by increasing demand for continuous cardiac rhythm monitoring and early arrhythmia detection
- Segmentation based on end-user shows that hospitals, cardiac care centers, and ambulatory surgical centers accounted for around 63% share of the United Kingdom Ambulatory Cardiac Monitoring Market, supported by rising cardiovascular disease prevalence, growing adoption of remote patient monitoring, and increasing emphasis on preventive cardiac healthcare.
Download the eBook (ToC)
- The United Kingdom Ambulatory Cardiac Monitoring Market is led by key players including Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, GE HealthCare, and Koninklijke Philips N.V., collectively holding around 56% share, driven by strong demand for advanced cardiac diagnostics, wearable monitoring devices, and remote patient monitoring solutions.
- Growing adoption of Holter monitors, mobile cardiac telemetry systems, wearable ECG devices, and AI-enabled cardiac monitoring platforms is improving arrhythmia detection accuracy, enhancing patient management efficiency by around 30%, and supporting the expansion of preventive cardiovascular care across the United Kingdom.
Why Buy This Report
- Provides a comprehensive analysis of the impact of rising cardiovascular disease prevalence, increasing adoption of remote patient monitoring, aging population trends, and advancements in wearable healthcare technologies on the growth of the United Kingdom Ambulatory Cardiac Monitoring Market across key healthcare settings.
- Offers key insights into technological advancements such as AI-enabled cardiac diagnostics, mobile cardiac telemetry systems, wearable ECG monitors, cloud-based patient monitoring platforms, and real-time data analytics used in ambulatory cardiac care.
- Helps market participants evaluate competitive benchmarking, investment opportunities in cardiac monitoring technologies, and expansion strategies of leading medical device manufacturers serving hospitals, cardiac care centers, ambulatory surgical centers, and home healthcare providers in the United Kingdom.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Ambulatory Cardiac Monitoring Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Ambulatory Cardiac Monitoring Market
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- GE HealthCare Technologies Inc.
- Koninklijke Philips N.V.
- Biotronik SE & Co. KG
- iRhythm Technologies, Inc.
- Baxter International Inc. (Hillrom)
- SCHILLER AG
- Nihon Kohden Corporation
Recent Developments:
- In April 2025, iRhythm Technologies, Inc. launched an enhanced version of its wearable cardiac monitoring solution in the United Kingdom, incorporating advanced AI-driven arrhythmia detection algorithms and cloud-based analytics to improve diagnostic accuracy and patient outcomes.
- In February 2025, GE HealthCare Technologies Inc. introduced a next-generation ambulatory ECG monitoring system in the United Kingdom, featuring extended monitoring duration, wireless connectivity, and real-time data sharing capabilities to support remote cardiac care and early diagnosis of cardiovascular conditions.
Market Segmentation:
United Kingdom Ambulatory Cardiac Monitoring Market, By Product Type
- Holter Monitors
- Event Monitors
- Mobile Cardiac Telemetry (MCT) Devices
- Implantable Loop Recorders (ILRs)
- Wearable ECG Monitors
United Kingdom Ambulatory Cardiac Monitoring Market, By Application
- Arrhythmia Detection & Monitoring
- Atrial Fibrillation Monitoring
- Cardiac Event Diagnosis
- Post-Stroke Cardiac Monitoring
- Remote Patient Monitoring
United Kingdom Ambulatory Cardiac Monitoring Market, By End user
- Hospitals
- Cardiac Care Centers
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Centers
- Home Healthcare Settings
- Specialty Clinics
Expert Views:
The United Kingdom Ambulatory Cardiac Monitoring Market is poised for sustained growth, driven by the increasing burden of cardiovascular diseases, expanding adoption of remote patient monitoring, and continuous advancements in wearable and AI-enabled diagnostic technologies. Growing emphasis on preventive healthcare, early arrhythmia detection, and home-based patient management is expected to strengthen market penetration and foster innovation across the cardiac monitoring ecosystem through 2035.
Author: Govind and Krishna By Spherical Insights and Consulting